CIK 0001743881
- Large accelerated filer
BridgeBio Pharma, Inc.
Sign in to watch- Ticker
- BBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 650-391-9740
- Business address
- 3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
- Former names
- BridgeBio Pharma LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,676,804
- in 3 filings, $1.7M under 10b5-1 plans
Net −$1,676,804. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-11-16 | HENDERSON MICHAEL THOMAS Chief Business Officer | Option exercise · Restricted Stock Units | −12,813 | 179,375 | ||
| 2020-11-16 | STEPHENSON BRIAN C See Remarks | Option exercise | +1,710 | 290,677 | ||
| 2020-11-16 | STEPHENSON BRIAN C See Remarks | Shares withheld for taxes | −592 | $44.33 | $26K | 290,085 |
| 2020-11-16 | STEPHENSON BRIAN C See Remarks | Option exercise · Restricted Stock Units | −1,710 | 23,937 | ||
| 2020-11-16 | Sinha Uma Chief Scientific Officer | Option exercise | +469 | 16,460 | ||
| 2020-11-16 | Sinha Uma Chief Scientific Officer | Option exercise · Restricted Stock Units | −469 | 6,563 | ||
| 2020-11-16 | Cook Jennifer E. Director | Option exercise | +3,576 | 3,576 | ||
| 2020-11-16 | Cook Jennifer E. Director | Option exercise · Restricted Stock Units | −3,576 | 3,576 | ||
| 2020-11-13 | MCCORMICK FRANK Chairman of Oncology | Sale | −31,632 | $42.22 | $1.3M | 1,268,836 |
| 2020-11-13 | MCCORMICK FRANK Chairman of Oncology | Sale | −58,299 | $42.91 | $2.5M | 1,210,537 |
| 2020-11-13 | MCCORMICK FRANK Chairman of Oncology | Sale | −10,069 | $43.57 | $439K | 1,200,468 |
| 2020-11-05 | Turtle Cameron See Remarks | Option exercise | +2,500 | $17.00 | $43K | 15,068 |
| 2020-11-05 | Turtle Cameron See Remarks | Sale | −2,500 | $42.05 | $105K | 12,568 |
| 2020-11-05 | Turtle Cameron See Remarks | Option exercise · Stock Option (Right to Buy) | −2,500 | 268,000 | ||
| 2020-11-02 | HENDERSON MICHAEL THOMAS Chief Business Officer | Option exercise | +10,000 | $1.05 | $11K | 277,751 |
| 2020-11-02 | HENDERSON MICHAEL THOMAS Chief Business Officer | Sale | −9,500 | $38.33 | $364K | 268,251 |
| 2020-11-02 | HENDERSON MICHAEL THOMAS Chief Business Officer | Sale | −500 | $38.92 | $19K | 267,751 |
| 2020-11-02 | HENDERSON MICHAEL THOMAS Chief Business Officer | Option exercise · Stock Option (Right to Buy) | −10,000 | 28,282 | ||
| 2020-10-16 | HOMCY CHARLES J Chairman of Pharmaceuticals | Option exercise | +10,256 | $17.00 | $174K | 1,214,023 |
| 2020-10-16 | HOMCY CHARLES J Chairman of Pharmaceuticals | Sale | −10,256 | $41.00 | $420K | 1,203,767 |
Page 43 of 44 · 868 trades